Sanofi Retained Earnings from 2010 to 2025

SNY Stock

USD 57.75 0.06 0.10%

Sanofi ADR Retained Earnings yearly trend continues to be fairly stable with very little volatility. Retained Earnings will likely drop to about 73.7 B in 2025. Retained Earnings is the cumulative amount of net income that Sanofi ADR retains for reinvestment in its operations, rather than distributing it to shareholders as dividends. View All Fundamentals

Retained Earnings

First Reported

2000-12-31

Previous Quarter

67.5 B

Current Value

65.1 B

Quarterly Volatility

57.3 T

Housing Crash

Credit Downgrade

Yuan Drop

Covid

Check Sanofi ADR financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Sanofi ADR's main balance sheet or income statement drivers, such as Depreciation And Amortization of 3.3 B, Interest Expense of 603.9 M or Selling General Administrative of 4.9 B, as well as many indicators such as Price To Sales Ratio of 3.91, Dividend Yield of 0.0235 or PTB Ratio of 1.44. Sanofi financial statements analysis is a perfect complement when working with Sanofi ADR Valuation or Volatility modules.

Check out the analysis of Sanofi ADR Correlation against competitors.

For more information on how to buy Sanofi Stock please use our How to Invest in Sanofi ADR guide.

Latest Sanofi ADR's Retained Earnings Growth Pattern

Below is the plot of the Retained Earnings of Sanofi ADR over the last few years. It is the cumulative amount of net income that a company retains for reinvestment in its operations, rather than distributing it to shareholders as dividends. Sanofi ADR's Retained Earnings historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Sanofi ADR's overall financial position and show how it may be relating to other accounts over time.

View

Last Reported 67.5 B

10 Years Trend

Pretty Stable

Compare to Others All Fundamentals

Retained Earnings

Timeline

Sanofi Retained Earnings Regression Statistics

	Arithmetic Mean	Huge
	Geometric Mean	138,046,103,096
	Coefficient Of Variation	400.00
	Mean Deviation	Huge
	Median	63,324,446,000
	Standard Deviation	Huge
	Sample Variance	62499992389199460000000T
	Range	1000000T
	R-Value	(0.14)
	Mean Square Error	65651253073054370000000T
	R-Squared	0.02
	Significance	0.60
	Slope	(Huge)
	Total Sum of Squares	937499885837992400000000T

Sanofi Retained Earnings History

	2025	73.7 B
	2024	77.6 B
	2023	67.5 B
	2022	66.7 B
	2021	63 B
	2020	60.1 B
	2019	51.8 B

Other Fundumenentals of Sanofi ADR

Retained Earnings Total Equity

Sanofi ADR Retained Earnings component correlations

	Total Assets	Total Stockholder Equity	Net Debt	Accounts Payable	Net Receivables	Good Will	Short Term Investments	Total Liab	Total Current Assets	Short Term Debt	Intangible Assets	Common Stock	Current Deferred Revenue	Retained Earnings	Long Term Debt	Property Plant Equipment	Treasury Stock	Deferred Long Term Liab	Long Term Investments	Short Long Term Debt	Net Tangible Assets	Long Term Debt Total	Capital Surpluse	Net Invested Capital	Net Working Capital	Capital Stock
Total Assets		0.99	0.65	0.86	0.97	0.98	-0.58	0.98	0.89	0.63	0.83	0.81	0.06	0.0	0.59	0.55	0.03	0.53	0.19	-0.53	0.04	0.6	0.58	0.49	-0.11	0.0
Total Stockholder Equity	0.99		0.56	0.87	0.96	0.96	-0.57	0.95	0.89	0.62	0.82	0.8	0.01	0.0	0.53	0.57	0.0	0.55	0.18	-0.5	0.15	0.56	0.53	0.5	-0.08	0.02
Net Debt	0.65	0.56		0.54	0.65	0.67	-0.33	0.76	0.45	0.52	0.67	0.48	0.22	-0.12	0.61	0.26	0.25	0.36	0.1	-0.33	-0.62	0.61	0.55	0.38	-0.41	-0.04
Accounts Payable	0.86	0.87	0.54		0.76	0.81	-0.19	0.83	0.86	0.48	0.71	0.43	-0.33	-0.12	0.32	0.25	0.0	0.78	0.16	-0.65	0.08	0.8	0.74	0.75	-0.18	0.07
Net Receivables	0.97	0.96	0.65	0.76		0.97	-0.67	0.96	0.81	0.63	0.85	0.87	0.17	-0.02	0.64	0.63	0.04	0.4	0.15	-0.39	0.04	0.46	0.43	0.36	-0.12	-0.05
Good Will	0.98	0.96	0.67	0.81	0.97		-0.6	0.97	0.82	0.57	0.8	0.83	0.13	0.0	0.67	0.56	-0.02	0.47	0.29	-0.55	-0.01	0.56	0.53	0.42	-0.2	-0.01
Short Term Investments	-0.58	-0.57	-0.33	-0.19	-0.67	-0.6		-0.57	-0.39	-0.26	-0.41	-0.83	-0.76	-0.2	-0.57	-0.65	0.17	0.31	0.15	0.16	0.0	0.12	0.06	0.26	0.17	0.15
Total Liab	0.98	0.95	0.76	0.83	0.96	0.97	-0.57		0.86	0.63	0.8	0.8	0.13	0.0	0.65	0.5	0.06	0.48	0.2	-0.55	-0.1	0.65	0.62	0.46	-0.14	-0.02
Total Current Assets	0.89	0.89	0.45	0.86	0.81	0.82	-0.39	0.86		0.57	0.57	0.62	-0.08	0.11	0.38	0.35	0.02	0.55	0.18	-0.6	0.23	0.7	0.71	0.5	0.16	0.0
Short Term Debt	0.63	0.62	0.52	0.48	0.63	0.57	-0.26	0.63	0.57		0.59	0.53	-0.02	0.1	0.18	0.31	0.35	0.35	0.14	0.07	-0.04	0.43	0.41	0.43	0.04	0.08
Intangible Assets	0.83	0.82	0.67	0.71	0.85	0.8	-0.41	0.8	0.57	0.59		0.69	-0.1	-0.22	0.44	0.5	0.18	0.6	0.02	-0.2	-0.09	0.45	0.36	0.57	-0.22	0.17
Common Stock	0.81	0.8	0.48	0.43	0.87	0.83	-0.83	0.8	0.62	0.53	0.69		0.41	0.1	0.67	0.73	0.0	0.08	0.11	-0.29	0.03	0.16	0.18	0.13	0.0	0.14
Current Deferred Revenue	0.06	0.01	0.22	-0.33	0.17	0.13	-0.76	0.13	-0.08	-0.02	-0.1	0.41		0.26	0.42	0.31	-0.24	-0.73	-0.13	0.11	-0.28	-0.41	-0.33	-0.71	-0.17	-0.4
Retained Earnings	0.0	0.0	-0.12	-0.12	-0.02	0.0	-0.2	0.0	0.11	0.1	-0.22	0.1	0.26		-0.12	-0.11	0.07	-0.19	0.15	-0.08	0.38	0.02	0.2	-0.24	0.06	-0.11
Long Term Debt	0.59	0.53	0.61	0.32	0.64	0.67	-0.57	0.65	0.38	0.18	0.44	0.67	0.42	-0.12		0.75	0.06	0.08	0.39	-0.47	-0.36	0.18	0.15	0.01	-0.14	-0.13
Property Plant Equipment	0.55	0.57	0.26	0.25	0.63	0.56	-0.65	0.5	0.35	0.31	0.5	0.73	0.31	-0.11	0.75		0.13	0.06	0.15	-0.13	0.1	-0.13	-0.16	-0.03	0.07	-0.06
Treasury Stock	0.03	0.0	0.25	0.0	0.04	-0.02	0.17	0.06	0.02	0.35	0.18	0.0	-0.24	0.07	0.06	0.13		0.27	0.0	0.24	0.01	0.32	0.33	0.24	-0.06	0.11
Deferred Long Term Liab	0.53	0.55	0.36	0.78	0.4	0.47	0.31	0.48	0.55	0.35	0.6	0.08	-0.73	-0.19	0.08	0.06	0.27		0.26	-0.42	0.09	0.74	0.65	0.85	-0.04	0.22
Long Term Investments	0.19	0.18	0.1	0.16	0.15	0.29	0.15	0.2	0.18	0.14	0.02	0.11	-0.13	0.15	0.39	0.15	0.0	0.26		-0.33	0.04	0.2	0.2	0.11	0.11	-0.09
Short Long Term Debt	-0.53	-0.5	-0.33	-0.65	-0.39	-0.55	0.16	-0.55	-0.6	0.07	-0.2	-0.29	0.11	-0.08	-0.47	-0.13	0.24	-0.42	-0.33		0.08	-0.64	-0.65	-0.47	0.14	-0.22
Net Tangible Assets	0.04	0.15	-0.62	0.08	0.04	-0.01	0.0	-0.1	0.23	-0.04	-0.09	0.03	-0.28	0.38	-0.36	0.1	0.01	0.09	0.04	0.08		-0.14	-0.05	-0.06	0.35	-0.08
Long Term Debt Total	0.6	0.56	0.61	0.8	0.46	0.56	0.12	0.65	0.7	0.43	0.45	0.16	-0.41	0.02	0.18	-0.13	0.32	0.74	0.2	-0.64	-0.14		0.98	0.77	-0.19	0.18
Capital Surpluse	0.58	0.53	0.55	0.74	0.43	0.53	0.06	0.62	0.71	0.41	0.36	0.18	-0.33	0.2	0.15	-0.16	0.33	0.65	0.2	-0.65	-0.05	0.98		0.69	-0.15	0.19
Net Invested Capital	0.49	0.5	0.38	0.75	0.36	0.42	0.26	0.46	0.5	0.43	0.57	0.13	-0.71	-0.24	0.01	-0.03	0.24	0.85	0.11	-0.47	-0.06	0.77	0.69		-0.11	0.59
Net Working Capital	-0.11	-0.08	-0.41	-0.18	-0.12	-0.2	0.17	-0.14	0.16	0.04	-0.22	0.0	-0.17	0.06	-0.14	0.07	-0.06	-0.04	0.11	0.14	0.35	-0.19	-0.15	-0.11		0.06
Capital Stock	0.0	0.02	-0.04	0.07	-0.05	-0.01	0.15	-0.02	0.0	0.08	0.17	0.14	-0.4	-0.11	-0.13	-0.06	0.11	0.22	-0.09	-0.22	-0.08	0.18	0.19	0.59	0.06

Click cells to compare fundamentals

About Sanofi ADR Financial Statements

Sanofi ADR investors use historical fundamental indicators, such as Sanofi ADR's Retained Earnings, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Sanofi ADR. Please read more on our technical analysis and fundamental analysis pages.

		Last Reported	Projected for Next Year
	Retained Earnings	77.6 B	73.7 B

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

V	Visa Class A
CRM	Salesforce
CRM	Salesforce

Additional Tools for Sanofi Stock Analysis

When running Sanofi ADR's price analysis, check to measure Sanofi ADR's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Sanofi ADR is operating at the current time. Most of Sanofi ADR's value examination focuses on studying past and present price action to predict the probability of Sanofi ADR's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Sanofi ADR's price. Additionally, you may evaluate how the addition of Sanofi ADR to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC